纳洛酮联合氨茶碱治疗小儿呼吸衰竭的临床疗效及安全性研究

目的研究纳洛酮联合氨茶碱在小儿呼吸衰竭治疗中的疗效与安全性。方法：将在我院接受治疗的呼吸衰竭患儿80例作为研究对象。应用数字随机法将其分为治疗组与对照组。对照组采用进行常规治疗方法治疗，治疗组在此基础上应用纳洛酮联合氨茶碱治疗。评定两组的治疗效果和安全性。结果：在临床治疗效果方面，治疗组显著优于对照组（P〈0．05），在患儿临床症状与体征缓解方面治疗组也显著优于对照组（P〈0．05）。结论：在常规治疗基础上加用纳洛酮联合氨茶碱对小儿呼吸衰竭进行治疗，临床疗效显著。

Objective efficacy and safety of naloxone plus aminophylline in treatment of pediatric respiratory failure. Methods：in our hospital received 80 cases in the treatment of respiratory failure patients as the research object, by random numbermethod will be the into treatment group and control group. Results： in the clinical treatment effec4 treatment group wassignificantly better than the control group （P 〈 0.05）, in children with clinical symptoms and signs of ease in the treatment groupwas significantly better than the control group （P 〈 0.05）. Conclusion： in on the basis of conventional therapy plus naloxone plusaminophylline of pediatric respiratory failure treatment, efficacy significantly.